Printer Friendly

AVECOR CARDIOVASCULAR TO BEGIN SELLING NEW OXYGENATOR

 MINNEAPOLIS, Nov. 23 /PRNewswire/ -- AVECOR Cardiovascular Inc. (NASDAQ: AVEC) has received clearance from the U.S. Food and Drug Administration to begin domestic marketing of its new Affinity oxygenator, the company announced today. The new oxygenator has been sold in Europe since July of 1993.
 Anthony Badolato, president and CEO, said training of sales representatives and distributors will begin immediately, with the first U.S. sales expected in January 1994.
 "The Affinity oxygenator is a state-of-the-art device with a superior design and performance capabilities," Badolato said. "It incorporates a unique radial flow design, developed through extensive computer modeling, that reduces the trauma to blood as it is oxygenated. Our computer-controlled manufacturing process allows us to wind hollow fiber bundles with extraordinary precision, enabling the Affinity to be both very compact and highly efficient. It will be priced competitively, and we believe it will be well-received in the marketplace."
 AVECOR Cardiovascular Inc., headquartered in Minneapolis, develops, manufactures and markets specialty disposable medical devices for heart/lung bypass surgery and long-term respiratory support. The company's current products include membrane oxygenators, cardiotomy reservoirs and cardioplegia systems.
 -0- 11/23/93
 /CONTACT: John Swenson, Swenson/Falker Associates, 612-371-0000, for AVECOR; or Norman McGibbon of AVECOR, 612-559-9504/
 (AVEC)


CO: AVECOR Cardiovascular Inc. ST: Minnesota IN: MTC SU: PDT

CP-DB -- MN006 -- 7122 11/23/93 08:29 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 23, 1993
Words:222
Previous Article:F & M RELEASES THIRD QUARTER EARNINGS
Next Article:FIRST DEPOSIT OFFERS LINE OF CREDIT
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters